Graves' ophthalmopathy--immunologic parameters related to corticosteroid therapy.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  1981-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 6970185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy.

  1979cited by this paper
• E-rosette formation in Graves' ophthalmopathy.

  1979cited by this paper
• Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis.

  1978cited by this paper
• The effects of single‐dose alternate‐day prednisone therapy on the immunological status of patients with neuromuscular diseases

  1978cited by this paper
• Modification of the classification of the eye changes of Graves' disease.

  1977cited by this paper
• Glucocorticoid receptors in corticosensitive and corticoresistant thymocyte subpopulations. II. Studies with hydrocortisone-treated mice.

  1977cited by this paper
• The active E rosette test: correlation with delayed cutaneous hypersensitivity.

  1976cited by this paper
• Glucocorticoid receptors in corticosensitive and corticoresistant thymocyte subpopulations. I. characterization of glucocorticoid receptors and isolation of a corticoresistant subpopulation.

  1976cited by this paper
• Alternate-day prednisone therapy and human lymphocyte subpopulations.

  1975cited by this paper
• Human lymphocyte subpopulations. Effect of corticosteroids.

  1974influential reference
• The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

  1974influential reference
• Optic neuropathy of graves's disease. Treatment by transantral or transfrontal orbital decompression.

  1974cited by this paper
• Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

  1973cited by this paper
• Supervoltage orbital radiotherapy for Graves' ophthalmopathy.

  1973cited by this paper
• Lymphocyte Transformation

  1972cited by this paper
• Thymus-Derived Lymphocytes: Humoral and Cellular Reactions Distinguished by Hydrocortisone

  1972cited by this paper
• Thyrotrophin-releasing hormone as a thyroid-function test.

  1971cited by this paper
• THYMUS-MARROW IMMUNOCOMPETENCE

  1971cited by this paper
• GLUCOCORTICOIDS AND CELLULAR IMMUNITY IN VITRO

  1970cited by this paper
• Prednisone in emergency treatment of malignant exophthalmos.

  1966cited by this paper
• Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone.

  1965cited by this paper
• THYROTOXICOSIS OCCURRING IN TWO PATIENTS ON PROLONGED HIGH DOSES OF STEROIDS.

  1964cited by this paper
• A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method.

  1955cited by this paper

• Predictive markers for anti-inflammatory treatment response in thyroid eye disease

  2023cites this paper
• Thyroid Eye Disease

  2016cites this paper
• Diagnosis and management of thyroid orbitopathy.

  2005cites this paper
• Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.

  2005cites this paper
• Assessment of Disease Activity

  2001cites this paper
• Tratamiento radioterápico en la oftalmopatía de Graves

  2001cites this paper
• Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment

  2001cites this paper
• Assessment of disease activity of Graves’ ophthalmopathy

  2000cites this paper
• Therapy of Graves’ Ophthalmopathy

  2000cites this paper
• Chemical injuries of the eye: current concepts in pathophysiology and therapy.

  1997cites this paper
• Evolution of Classification Systems for Graves' Ophthalmopathy

  1995cites this paper
• The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

  1994cites this paper
• Graves' ophthalmopathy: current concepts regarding pathogenesis and management.

  1993cites this paper
• Advances in thyroid orbitopathy

  1992cites this paper
• Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.

  1992cites this paper
• Re-examination of peripheral blood T cell subsets in dysthyroid orbitopathy.

  1992cites this paper
• High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy.

  1992cites this paper
• Why the NOSPECS Classification of Graves' Eye Disease Should Be Abandoned, with Suggestions for the Characterization of This Disease

  1992cites this paper
• The ophthalmopathy of Graves' disease.

  1991cites this paper
• Treatment of acute Graves orbitopathy.

  1991cites this paper
• Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

  1989cites this paper
• Management of endocrine orbitopathy.

  1988cites this paper
• Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy.

  1988cites this paper
• Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy.

  1987cites this paper
• The role of T lymphocytes in autoimmune thyroid disease.

  1987cites this paper
• Lid retraction or no lid retraction in optic neuropathy with proptosis.

  1985cites this paper
• Oculocutaneous Manifestations of Thyroid Disease

  1985cites this paper
• Diagnosis and management of endocrine ophthalmopathy.

  1985cites this paper
• Lymphocyte subpopulations in Graves' ophthalmopathy.

  1985cites this paper
• [Therapy of orbital and retroorbital space occupying processes with optic nerve compression].

  1985cites this paper
• The management of ophthalmic Graves' disease.

  1984cites this paper
• Lymphocyte subset distribution in Graves' ophthalmopathy patients: increased levels of B cells

  1984cites this paper
• Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.

  1984cites this paper
• [Classification and clinical characteristics of endocrine ophthalmopathy].

  1983cites this paper
• Association of HLA antigen BW35 with severe Graves' ophthalmopathy.

  1983cites this paper
• Radiation therapy for Graves' disease.

  1983cites this paper
• Clinicohistopathologic correlations in xerophthalmic ulceration and necrosis.

  1982cites this paper
• Immunosuppression and selective inflammatory cell depletion. Studies on a guinea pig model of corneal ulceration after ocular alkali burning.

  1982cites this paper
• Corneal Xerophthalmia and Keratomalacia-Reply

  1982cites this paper
• Idiopathic orbital myositis: report of six cases.

  1982cites this paper
• Graves' ophthalmopathy. A clinical and immunologic review.

  1981cites this paper
• The clinical immunology of Graves' ophthalmopathy.

  1981cites this paper
• Clinical Ophthalmology Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Update on Thyroid Eye Disease and Management

  year unknowncites this paper